维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="ADLER CH"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI显示文摘	Litvan I Aarsland D Adler CH	2011	Mov Disord2011，26，10：	1
2	MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI 显示文摘	Litvan I Aarsland D Adler CH	2011	Mov Disord2011，26，10：	1
3	Nonmotor eomplieations in Parkinson' s disease显示文摘	Adler CH	2005	Mov Disord2005，20，11：	1
4	Multi-organ distribution of phosphorylated alpha - synuclein histopathology in subjects with Lewy body disorders 显示文摘	Beach TG Adler CH Sue LI	2010	Acta Neuropathol2010，119，6：	1
5	Parkinson's disese dementia: comparing patients with and without Alzheimer pathology 显示文摘	Sabbagh MN Adler CH Lahti TJ	2013	Nat Rev Neurosei2013，14，3：	1
6	Genetics of restless legs syndrome 显示文摘	Mata IF Bodkin CL Adler CH	2006	Parkinsomsm Relat Disord2006，12，1：	1
7	MDS clinical diagnostic criteria for Parkinson's disease 显示文摘	Postuma RB Berg D Stern M Poewe W Olanow CW Oertel W Obeso J Marek K Litvan I Lang AE Halliday G Goetz CG Gasser T Dubois B Chan P Bloem BR Adler CH Deuschl G	2015	Mov Disord2015，30，12：	1
8	Hemifacial spasm and other craniofacial movement disorders显示文摘	Adler CH	1998	Mayo Clinic Proc1998，73，：	1
9	Heterogeneous neuro- pathological findings in Parkinson's disease with mild cognitive impairment 显示文摘	Adler CH Caviness JN Sabbagh MN	2010	Acta Neuropathol2010，120，6：	1
10	Pathology in essential tremor显示文摘	Shill HA Adler CH Beacb TG	2012	Parkinsonism Relat Disord2012，18，1：	1
11	Clinical efficacy and safety of IV ferric carboxymaltose( FCM) treatment of RLS: a multi-centred, pla?cebo-controlled preliminary clinical trial显示文摘	Allen RP Adler CH Du W	2011	Sleep Med2011，12，9：	1
12	Hemifacial spasm:evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography显示文摘	Zimmerman RA Savino PJ	1992	Ann Neurol1992，32，：	1
13	Low clinical diagnostic accuracy of early vs advanced Parkinson disease:clinicopathologic study显示文摘	Adler CH Beach TG Hentz JG	2014	Neurology2014，83，5：	1
14	A novel predictor of cancer malignancy:up-regulation of myristoylated alanine-rich C kinase Substrate phosphorylation in lung cancer显示文摘	Chen CH Chiu CL Adler KB	2014	Am J Respir Crit Care Med2014，189，8：	1
15	Clinical efficacy and safety of Ⅳ ferric carboxymaltose (FCM) treatment of RLS:a multi-centred,placebo-controlled preliminary clinical trial显示文摘	Allen RP Adler CH Du W	2011	Sleep Med2011，12，9：	1
16	Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction 显示文摘	Beach TG Adler CH Lue L	2009	Acta Neuro- patho12009，117，6：	1
17	Safety and efficacey of Neurobloc (botulinum toxin type B)in type A- resistant cervical dystonia显示文摘	Brin MF Lew MF Adler CH	1999	Neurology1999，53，7：	1
18	MDS research criteria for prodromal Parkinson's disease显示文摘	Berg D Postuma RB Adler CH	2015	Mov Disord2015，30，12：	1
19	Pharmacological and surgical options for the treatment of cervical dystonia 显示文摘	Adler Ch Kumar R	2000	Neurology2000，55，：	1
20	A pilot study on the moter effects of rimantadine in parkinson's disease 显示文摘	Evidente VG Adler CH Caviness JN	1999	Clin Neurophamacol1999，22，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示